免疫接种后不良事件:急性呼吸窘迫综合征(ARDS)病例定义与数据收集、分析及呈现指南
布莱顿协作组织在流行病防范创新联盟(CEPI)支持下,召集专家制定免疫接种后ARDS的病例定义与确定性分级。该定义基于文献 exhaustive 回顾与专家咨询形成共识,并经同行评议,用于免疫接种后不良事件的评估。
要点
- 提供免疫接种后ARDS的标准化病例定义及确定性分级。
- 适用于SARS-CoV-2等新发病原体疫苗安全性监测。
- 遵循布莱顿协作病例定义格式,经同行评议。
核心结论
- 形成免疫接种后ARDS的共识性病例定义与确定性分级,用于不良事件评估。
研究设计与样本
- 由CEPI召集的专家组制定,遵循布莱顿协作病例定义格式,经文献回顾和专家咨询形成共识,并经同行评议。
临床怎么用
- 用于免疫接种后ARDS病例的标准化识别、数据收集、分析与呈现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This is a Brighton Collaboration Case Definition of the term "Acute Respiratory Distress Syndrome - ARDS" to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2 vaccines and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected Expert Reviewers prior to submission. The comments of the reviewers were taken into consideration and edits incorporated in this final manuscript.
引用
- Serazin NA, Edem B, Williams SR, et al. Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021. PMID: 33583673. doi:10.1016/j.vaccine.2021.01.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。